Cell line · CVCL_6911
HEK293-FT
Transformed cell line, Homo sapiens. 256 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. HEK293-FT. Cell lines, record CVCL_6911. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_6911
On this page
Cell line
As Cellosaurus gives it.
- Name
- HEK293-FT
- Accession
- CVCL_6911
- RRID
- RRID:CVCL_6911
- Synonyms
- HEK-293FT, HEK 293FT, HEK-293-FT, HEK293FT, 293-FT, 293FT, FT-293
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- Fetus
- Category
- Transformed cell line
- Derived from
- Fetal kidney (in situ)
- Parent
- HEK293-F (CVCL_6642)
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers256
7 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Mitochondrial transfer between breast cancer cells promotes ROS-dependent proliferation. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Genetically inducible coordinators of cytokine signaling pathways for interrogating T cell motility. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ULK1-dependent autophagy initiation promotes MHC-I degradation and immune evasion in HPV-positive head and neck cancer. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| APOBEC3 activity and DNA polymerase-ε deficiency are associated with distinct IDH1 R132 hotspot mutations. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pharmacological Blockade of NMUR2 Suppresses Glioma Growth by Inhibiting STAT5-Mediated Transcription of Cell Cycle-associated Genes. | Int J Biol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| In-cell cryo-electron tomography reveals differential effects of type I and type II kinase inhibitors on LRRK2 filament formation and microtubule association. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The alternative polyadenylation factor CFIm25 orchestrates macrophage antibacterial activity against Salmonella through the TAB2 and TBL1XR1 regulators of MAPK and NF-κB signaling. | Infect Immun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Alpelisib enhances cisplatin mediated cytotoxicity in non-mutated, PIK3CA-dependent high-grade serous ovarian cancer. | J Ovarian Res | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 256
See all 256 papersRelatives4
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | HEK293-F | CVCL_6642 | Cell lines | |
| Derived from it | HEK293-FT APEX1 KO clone 1C4 | CVCL_B0WA | Cell lines | |
| Derived from it | HEK293-FT APEX1 KO clone 2A9 | CVCL_B0WB | Cell lines | |
| Derived from it | HyCyte HEK293-FT KO-hFURIN | CVCL_F1PD | Cell lines |
Cell banks1
| Cell bank | Catalog number | Status |
|---|---|---|
| CLS | 305275 |
Source CLS
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_6911
GET https://conductscience.org/api/cell-lines/v1/CVCL_6911/papers?page=2